Gene Bio Tech Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
55,037
51,589
52,256
55,632
55,534
Cost of Goods Sold (COGS) incl. D&A
48,211
44,011
44,526
45,095
45,885
Gross Income
6,826
7,578
7,730
10,537
9,648
SG&A Expense
6,586
6,496
6,568
7,013
7,250
EBIT
165
1,011
1,067
3,445
2,289
Unusual Expense
188
71
-
-
-
Non Operating Income/Expense
402
159
620
301
253
Interest Expense
1,134
912
794
357
306
Pretax Income
560
503
1,043
3,483
2,305
Income Tax
272
356
459
949
458
Consolidated Net Income
832
146
584
2,535
1,847
Net Income
204
1,091
1,712
2,734
2,089
Net Income After Extraordinaries
204
1,091
1,712
2,734
2,089
Net Income Available to Common
204
1,091
1,712
2,734
2,089
EPS (Basic)
31.00
160.00
220.00
318.00
243.00
Basic Shares Outstanding
7
7
8
9
9
EPS (Diluted)
39.33
148.06
219.21
315.04
242.61
Diluted Shares Outstanding
8
8
8
9
9
EBITDA
1,635
2,436
2,548
4,959
3,796
Other Operating Expense
75
72
95
79
109
Non-Operating Interest Income
195
316
151
94
69
Minority Interest Expense
1,036
944
1,128
199
242
About Gene Bio Tech Co.
View Profile
